Patel N, Kamath N, Smith C E, Pinchak A C, Hagen J H
Department of Anesthesiology, Case Western Reserve University, Cleveland, Ohio 44109, USA.
Can J Anaesth. 1997 Jan;44(1):49-53. doi: 10.1007/BF03014324.
To evaluate the tracheal intubating conditions and neuromuscular blocking characteristics of divided dose mivacurium or single dose rocuronium.
Thirty-two patients undergoing elective surgery were studied. Anaesthesia was with propofol 2 mg.kg-1, followed by an infusion of 150 micrograms.kg-1.min.1. Patients were randomized to receive either mivacurium-0.15 mg.kg-1 followed 30 sec later by 0.1 mg.kg-1, or rocuronium- 0.9 mg.kg-1, followed 30 sec later by placebo. Tracheal intubating conditions were assessed 90 sec after the initial dose of relaxant by an anaesthetists who was unaware of patient group. The electromyographic (EMG) response of the first dorsal interosseus muscle to ulnar nerve train-of-four was measured.
Successful tracheal intubation was performed in all patients after both mivacurium and rocuronium. Intubating conditions (jaw relaxation, open visible vocal cords) were judged to be good-excellent in all but one patient before insertion of the tracheal tube. However, patients receiving mivacurium were more likely to experience coughing and bucking after tracheal tube insertion (10/16 patients) than those receiving rocuronium (3/16 patients, P < 0.05). No patient in the rocuronium group experienced moderately vigorous coughing and bucking after insertion of the tracheal tube vs six patients in the mivacurium group (P < 0.05). Time to 10 and 25% recovery of neuromuscular function was faster (P < 0.05) after divided dose mivacurium (20 +/- 1 and 23 +/- 1 min, respectively) than after rocuronium (45 +/- 5 and 57 +/- 8 min, respectively).
The results suggest that, during conditions of the study, divided dose mivacurium is not recommended for a 90-sec tracheal intubation in patients where moderate coughing and bucking is deemed unacceptable.
评估分次给药米库氯铵或单次给药罗库溴铵的气管插管条件及神经肌肉阻滞特性。
对32例行择期手术的患者进行研究。麻醉诱导采用丙泊酚2mg·kg-1,随后以150μg·kg-1·min-1的速度持续输注。患者被随机分为两组,一组接受米库氯铵0.15mg·kg-1,30秒后再给予0.1mg·kg-1;另一组接受罗库溴铵0.9mg·kg-1,30秒后给予安慰剂。在给予首剂肌松药90秒后,由一名不知患者分组情况的麻醉医生评估气管插管条件。测量第一背侧骨间肌对尺神经四个成串刺激的肌电图(EMG)反应。
米库氯铵和罗库溴铵组所有患者均成功进行了气管插管。在插入气管导管前,除1例患者外,所有患者的插管条件(下颌松弛、声带可见开放)均被判定为良好至优秀。然而,与接受罗库溴铵的患者(3/16例)相比,接受米库氯铵的患者在气管导管插入后更易出现咳嗽和呛咳(10/16例,P<0.05)。罗库溴铵组无患者在气管导管插入后出现中度剧烈咳嗽和呛咳,而米库氯铵组有6例患者出现(P<0.05)。分次给药米库氯铵后神经肌肉功能恢复至10%和25%的时间(分别为20±1分钟和23±1分钟)比罗库溴铵后更快(分别为45±5分钟和57±8分钟,P<0.05)。
结果表明,在本研究条件下,对于中度咳嗽和呛咳被认为不可接受的患者,不建议使用分次给药米库氯铵进行90秒的气管插管。